Basic Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2006; 12(5): 716-722
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.716
Figure 2
Figure 2 Concentration- and time-dependent activation of MAP kinases after IL-1β treatment. (A) To obtain dose-dependent course of p44/42 MAP kinase and p38 MAP kinase, the cat ESMCs were treated with IL-1β for 3 and 18 h, respectively. The levels of p44/42 MAP kinase and p38 MAP kinase phosphorylation were increased above a dose of 10 ng/mL, which was maintained up to 50 ng/mL. (B) After treatment the cells with IL-1β (25 ng/mL), the level of p44/42 MAP kinase phosphorylation reached a maximum within 3 h with a subsequent decrease to the basal level (upper panel). The phosphorylated forms of p38 MAP kinase were increased within 12 h, which were sustained to 24 h.